Table 5.
Multivariable logistic regression of long-term carbapenem therapy (>8 days).
| Variable | β | Odds Ratio | 95% Confidence Interval | p-Value |
|---|---|---|---|---|
| Age | −0.014 | 0.986 | 0.973–1.001 | 0.059 |
| Granulocytes | 0.000 | 1.000 | 1.000–1.000 | 0.127 |
| Outpatient onset | 0.533 | 1.704 | 1.030–2.818 | 0.038 * |
| Diabetes mellitus | 0.423 | 1.527 | 0.804–2.897 | 0.196 |
| COPD | 2.132 | 8.436 | 1.067–66.667 | 0.043 * |
| Indwelling urinary catheter | −0.406 | 0.666 | 0.421–1.056 | 0.084 |
| FUO | −0.257 | 0.773 | 0.461–1.296 | 0.329 |
| CDI | 0.281 | 1.325 | 0.750–2.341 | 0.333 |
| Acute myeloid leukemia | 0.539 | 1.715 | 1.057–2.782 | 0.029 * |
| Malignant lymphoma | −0.342 | 0.710 | 0.438–1.151 | 0.165 |
| Multiple myeloma | −1.010 | 0.364 | 0.168–0.792 | 0.011 * |
| ESBL and AmpC | 1.036 | 2.819 | 1.382–5.750 | 0.004 * |
No. (%) or median (interquartile range). Abbreviations are as follows: COPD, chronic obstructive pulmonary disease; FUO, fever of unknown origin; CDI, clinical documented infection; ESBL, extended spectrum β-lactamases. * p < 0.05.